Key Takeaway
MEDVi vs BreezeMeds GLP-1 weight loss comparison for 2026. Pricing, medications, clinical support, and which platform is right for your weight loss goals.
Bottom line: BreezeMeds lives up to its name with a fast, friction-free path to compounded GLP-1 medication at competitive prices. MEDVi provides more clinical substance, with physician-led care and included metabolic lab work. For patients who want speed and simplicity at a lower cost, BreezeMeds delivers. For patients who want a more thorough medical program with ongoing lab monitoring, MEDVi is the better investment. The right choice depends on how much clinical infrastructure you want around your GLP-1 prescription.
Quick Comparison
| Feature | MEDVi | BreezeMeds |
|---|---|---|
| Monthly cost | $249-$399/mo | $149-$299/mo |
| Consultation fee | Included | Included |
| Medications offered | Compounded semaglutide, tirzepatide | Compounded semaglutide, tirzepatide |
| Provider type | Board-certified physicians | Licensed providers (NPs, PAs, MDs) |
| Lab work | thorough panel included | Not included |
| Time to first shipment | 7-10 days | 3-5 days |
| App/portal | Basic portal | Simplified portal |
| Follow-up model | Scheduled physician check-ins | Patient-initiated messaging |
| Shipping | Free standard | Free |
| States available | 30+ | 25+ states |
Pricing Breakdown
BreezeMeds is one of the more affordable compounded GLP-1 options on the market. Plans start around $149/month for lower-dose compounded semaglutide, with tirzepatide options topping out around $299. MEDVi's $249-$399 range reflects its more thorough clinical offering.
View data table
| Category | Overall Value Score | Detail |
|---|---|---|
| FormBlends | 92 | From $299/mo, physician-led |
| Hims/Hers | 78 | Consumer brand, varies |
| Ro | 75 | Telehealth platform |
| Calibrate | 70 | Metabolic health focus |
The $100/month gap adds up. Over six months, choosing BreezeMeds over MEDVi could save $600 or more. Whether that savings matters depends on what you give up. With BreezeMeds, you forgo included lab work, proactive physician follow-ups, and the deeper clinical assessments that MEDVi builds into its program.
For patients who have a primary care doctor running their metabolic panels and monitoring their health independently, that trade-off makes perfect sense. For patients who want everything managed under one roof, MEDVi's higher price includes services that would cost hundreds of dollars to arrange separately.
Medications Available
The medication options are importantly the same. Both platforms offer compounded semaglutide and compounded tirzepatide from licensed compounding pharmacies. Neither offers brand-name GLP-1 products.
Not sure which GLP-1 is right for you?
Take a 2-minute assessment and get a personalized recommendation after licensed provider review.
Take the Assessment →BreezeMeds has improved its pharmacy relationships for speed. Most patients receive their first shipment within 3-5 business days of completing their consultation. MEDVi's process takes longer (7-10 days) because the lab work component introduces additional turnaround time before prescriptions are finalized.
For dose titration, MEDVi's physicians actively manage escalation based on lab results, side effect reports, and progress tracking. BreezeMeds provides standard titration schedules, with patients expected to reach out if adjustments are needed.
Patient Experience
BreezeMeds has built its platform around speed and minimal friction. The onboarding questionnaire is concise, consultations are focused, and the path from intake to medication is as short as possible. For patients who value efficiency, this is a genuine strength.
MEDVi takes the opposite approach, prioritizing thoroughness over speed. Longer intake questionnaires, detailed medical history reviews, lab orders before prescribing, and scheduled follow-ups create a more traditional medical experience. It takes longer to get started but creates a more complete clinical picture.
Both platforms use basic patient portals. Neither has invested in a standout app experience. The portals handle messaging, prescription management, and appointment scheduling without much polish.
Provider Quality and Support
MEDVi uses board-certified physicians for all consultations. BreezeMeds uses a mix of licensed providers, including nurse practitioners and physician assistants. Both are qualified to prescribe GLP-1 medications.
The depth of engagement differs. MEDVi providers spend more time per interaction and proactively schedule follow-ups. BreezeMeds providers are responsive when contacted but don't typically initiate follow-up conversations. This works well for self-directed patients but can leave less engaged patients without adequate guidance.
Customer support at both platforms is business-hours messaging with generally responsive turnaround times.
Pros and Cons
MEDVi
Pros:
- Physician-led consultations
- thorough metabolic lab work included
- Proactive scheduled follow-ups
- Physician-guided dose titration
- More thorough health assessments
Cons:
- Higher monthly cost
- Slower time to first shipment (7-10 days)
- Basic digital platform
- Overkill for patients who just want medication access
BreezeMeds
Pros:
- Lower monthly pricing
- Fast onboarding (3-5 days to first shipment)
- Simplified, no-fuss process
- Good for experienced GLP-1 users
- No unnecessary extras inflating cost
Cons:
- No lab work included
- Patient-initiated follow-ups only
- Less clinical depth
- Smaller state coverage
- Not ideal for patients needing close monitoring
Who Should Choose MEDVi
MEDVi is the better choice for first-time GLP-1 patients, patients with comorbidities, and anyone who wants lab-based monitoring built into their program. If you don't have a primary care doctor actively managing your health, MEDVi fills some of that gap.
Who Should Choose BreezeMeds
BreezeMeds is ideal for patients who want affordable medication access with fast turnaround. If you're otherwise healthy, have experience with GLP-1 medications, or have a separate doctor managing your general health, BreezeMeds gives you what you need at a price that makes long-term treatment feasible.
How FormBlends Compares
FormBlends offers physician-supervised telehealth that combines GLP-1 weight loss medication with peptide wellness therapy. Patients get the clinical depth of MEDVi's physician-led model alongside treatment options that extend beyond weight loss into recovery, energy, and metabolic improvement. For patients who want more than a medication delivery service but also want more than a single-focus weight loss program, FormBlends offers a broader approach. Details are available at FormBlends.com.
Frequently Asked Questions
How quickly can I get medication from BreezeMeds?
BreezeMeds typically ships within 1-2 business days of an approved consultation, with most patients receiving medication within 3-5 business days total. This is faster than most competitors, including MEDVi.
Is MEDVi's lab work worth the extra cost?
It depends on your situation. If you don't have a doctor ordering metabolic panels for you, MEDVi's included labs provide valuable health data that can inform treatment decisions and catch potential issues. If you already get regular bloodwork, you're paying for redundancy.
Do either platform offer oral GLP-1 medications?
Neither platform currently offers oral semaglutide (Rybelsus) or other oral GLP-1 formulations as part of their standard programs. Both focus on injectable compounded formulations.
Can I cancel BreezeMeds at any time?
Yes. BreezeMeds operates on a month-to-month basis with no long-term contracts or cancellation fees. You can pause or cancel before your next billing cycle.
Which platform is better for patients over 50?
MEDVi's included lab work and more thorough medical assessments make it the safer choice for older patients who may have undiagnosed metabolic issues. The physician-led model also provides more clinical oversight for managing potential medication interactions.
Exploring physician-supervised GLP-1 therapy with peptide wellness protocols? See how FormBlends works and find out if it's the right fit.